These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 17078868)

  • 1. Suppression of breast cancer cell growth by Na+/H+ exchanger regulatory factor 1 (NHERF1).
    Pan Y; Wang L; Dai JL
    Breast Cancer Res; 2006; 8(6):R63. PubMed ID: 17078868
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Breast cancer-derived K172N, D301V mutations abolish Na+/H+ exchanger regulatory factor 1 inhibition of platelet-derived growth factor receptor signaling.
    Cheng S; Li Y; Yang Y; Feng D; Yang L; Ma Q; Zheng S; Meng R; Wang S; Wang S; Jiang WG; He J
    FEBS Lett; 2013 Oct; 587(20):3289-95. PubMed ID: 24012959
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NHERF (Na+/H+ exchanger regulatory factor) gene mutations in human breast cancer.
    Dai JL; Wang L; Sahin AA; Broemeling LD; Schutte M; Pan Y
    Oncogene; 2004 Nov; 23(53):8681-7. PubMed ID: 15467753
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Na+/H+ exchanger regulatory factor 1 inhibits platelet-derived growth factor signaling in breast cancer cells.
    Pan Y; Weinman EJ; Dai JL
    Breast Cancer Res; 2008; 10(1):R5. PubMed ID: 18190691
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Novel NHERF1 Mutation in Human Breast Cancer Inactivates Inhibition by NHERF1 Protein in EGFR Signaling.
    DU G; Hao C; Gu Y; Wang Z; Jiang WG; He J; Cheng S
    Anticancer Res; 2016 Mar; 36(3):1165-73. PubMed ID: 26977012
    [TBL] [Abstract][Full Text] [Related]  

  • 6. EBP50 exerts tumor suppressor activity by promoting cell apoptosis and retarding extracellular signal-regulated kinase activity.
    Zheng JF; Sun LC; Liu H; Huang Y; Li Y; He J
    Amino Acids; 2010 Apr; 38(4):1261-8. PubMed ID: 20012548
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The cellular distribution of Na+/H+ exchanger regulatory factor 1 is determined by the PDZ-I domain and regulates the malignant progression of breast cancer.
    Du G; Gu Y; Hao C; Yuan Z; He J; Jiang WG; Cheng S
    Oncotarget; 2016 May; 7(20):29440-53. PubMed ID: 27097111
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of Na+/H+ exchanger regulatory factor 1 in autosomal-dominant polycystic kidney disease.
    Wang JQ; Qin F; Zhu L
    J Int Med Res; 2015 Oct; 43(5):629-38. PubMed ID: 26142394
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Novel NHERF1 Mutation in Human Breast Cancer and Effects on Malignant Progression.
    Yang X; Du G; Yu Z; Si Y; Martin TA; He J; Cheng S; Jiang WG
    Anticancer Res; 2017 Jan; 37(1):67-73. PubMed ID: 28011475
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interferon regulatory factor-1 (IRF-1) exhibits tumor suppressor activities in breast cancer associated with caspase activation and induction of apoptosis.
    Bouker KB; Skaar TC; Riggins RB; Harburger DS; Fernandez DR; Zwart A; Wang A; Clarke R
    Carcinogenesis; 2005 Sep; 26(9):1527-35. PubMed ID: 15878912
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Na+/H+ exchanger regulatory factor 1 expression levels in blood and tissue predict breast tumour clinical behaviour.
    Bellizzi A; Mangia A; Malfettone A; Cardone RA; Simone G; Reshkin SJ; Paradiso A
    Histopathology; 2011 Jun; 58(7):1086-95. PubMed ID: 21707710
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The scaffolding protein NHERF1 sensitizes EGFR-dependent tumor growth, motility and invadopodia function to gefitinib treatment in breast cancer cells.
    Bellizzi A; Greco MR; Rubino R; Paradiso A; Forciniti S; Zeeberg K; Cardone RA; Reshkin SJ
    Int J Oncol; 2015 Mar; 46(3):1214-24. PubMed ID: 25530180
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biological role of NHERF1 protein expression in breast cancer.
    Mangia A; Chiriatti A; Bellizzi A; Malfettone A; Stea B; Zito FA; Reshkin SJ; Simone G; Paradiso A
    Histopathology; 2009 Nov; 55(5):600-8. PubMed ID: 19912366
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DMP1β, a splice isoform of the tumour suppressor DMP1 locus, induces proliferation and progression of breast cancer.
    Maglic D; Stovall DB; Cline JM; Fry EA; Mallakin A; Taneja P; Caudell DL; Willingham MC; Sui G; Inoue K
    J Pathol; 2015 May; 236(1):90-102. PubMed ID: 25537728
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NHERF1 Enhances Cisplatin Sensitivity in Human Cervical Cancer Cells.
    Tao T; Yang X; Qin Q; Shi W; Wang Q; Yang Y; He J
    Int J Mol Sci; 2017 Jan; 18(1):. PubMed ID: 28085111
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The prognostic value of the Na⁺/ H⁺ exchanger regulatory factor 1 (NHERF1) protein in cancer.
    Saponaro C; Malfettone A; Dell'Endice TS; Brunetti AE; Achimas-Cadariu P; Paradiso A; Mangia A
    Cancer Biomark; 2014; 14(2-3):177-84. PubMed ID: 24878819
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Establishment of HIV-1 model cell line GHOST(3) with stable DRiP78 and NHERF1 knockdown.
    Zhang L; Huang XH; Zhou PP; Yu GL; Yan J; Qin B; Yan XG; Diao LM; Lin P; Kuang YQ
    Dongwuxue Yanjiu; 2015 May; 36(3):161-6. PubMed ID: 26018859
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Na(+)/H(+) exchanger regulatory factor 1 (NHERF1) is required for the estradiol-dependent increase of phosphatase and tensin homolog (PTEN) protein expression.
    Yang L; Wang Y; Chen P; Hu J; Xiong Y; Feng D; Liu H; Zhang H; Yang H; He J
    Endocrinology; 2011 Dec; 152(12):4537-49. PubMed ID: 21990315
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Semaphorin-plexin signalling genes associated with human breast tumourigenesis.
    Gabrovska PN; Smith RA; Tiang T; Weinstein SR; Haupt LM; Griffiths LR
    Gene; 2011 Dec; 489(2):63-9. PubMed ID: 21925246
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gene expression profiling of luminal B breast cancers reveals NHERF1 as a new marker of endocrine resistance.
    Karn T; Ruckhäberle E; Hanker L; Müller V; Schmidt M; Solbach C; Gätje R; Gehrmann M; Holtrich U; Kaufmann M; Rody A
    Breast Cancer Res Treat; 2011 Nov; 130(2):409-20. PubMed ID: 21203899
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.